UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Respiratory syncytial virus fusion inhibitors. Part 7: Structure–activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (16), p.4857-4862

2009

Volltextzugriff (PDF)

Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability

Bioorganic & medicinal chemistry letters, 2007-02, Vol.17 (4), p.895-901

2007

Volltextzugriff (PDF)

Respiratory syncytial virus fusion inhibitors. Part 5: Optimization of benzimidazole substitution patterns towards derivatives with improved activity

Bioorganic & medicinal chemistry letters, 2007-08, Vol.17 (16), p.4592-4598

2007

Volltextzugriff (PDF)

Respiratory syncytial virus fusion inhibitors. Part 6: An examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety

Bioorganic & medicinal chemistry letters, 2007-09, Vol.17 (17), p.4784-4790

2007

Volltextzugriff (PDF)

Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo

Bioorganic & medicinal chemistry letters, 2006-03, Vol.16 (5), p.1115-1122

2006

Volltextzugriff (PDF)

Synthesis and antiviral activity of enantiomeric forms of cyclobutyl nucleoside analogs

Journal of medicinal chemistry, 1991-04, Vol.34 (4), p.1415-1421

1991

Volltextzugriff (PDF)

Respiratory syncytial virus inhibitors. Part 2: Benzimidazol-2-one derivatives

Bioorganic & medicinal chemistry letters, 2004-03, Vol.14 (5), p.1133-1137

2004

Volltextzugriff (PDF)

Development of a photoaffinity label for respiratory syncytial virus inhibitors

Journal of labelled compounds & radiopharmaceuticals, 2003-10, Vol.46 (12), p.1105-1116

2003

Volltextzugriff (PDF)

INHIBITION OF HERPES SIMPLEX VIRUS TYPE 1 DNA POLYMERASE BY THE NATURAL PRODUCT OOSPOREIN

The Journal of Antibiotics, 1992/02/25, Vol.45(2), pp.286-288

1992

Volltextzugriff (PDF)

Discovery and Development of Orally Active RSV Fusion Inhibitors

Antiviral Drugs, 2011, p.353-366

2011

Volltextzugriff (PDF)

Antiviral Drug Discovery

Drug Discovery, 2013, p.439-515

2013

Volltextzugriff (PDF)

Corrigendum to “Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability” [Bioorg. Med. Chem. Lett. 17 (2007) 895–901]

Bioorganic & medicinal chemistry letters, 2007-04, Vol.17 (8), p.2385-2385

2007

Volltextzugriff (PDF)

Inhibition of herpes simplex virus type 1 DNA polymerase by [1R(1 alpha,2 beta,3 alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl] guanine

Molecular pharmacology, 1991-10, Vol.40 (4), p.591-596

1991

Volltextzugriff (PDF)

Neutralization of purified herpes simplex virus DNA polymerase by two antipeptide sera

Virus genes, 1990-04, Vol.3 (4), p.343-354

1990

Volltextzugriff (PDF)

Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018

British journal of general practice, 2020-07, Vol.70 (696), p.e444-e449

2020

Volltextzugriff (PDF)

5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors

Journal of medicinal chemistry, 2019-02, Vol.62 (3), p.1348-1361

2019

Volltextzugriff (PDF)

Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers

Proceedings of the National Academy of Sciences - PNAS, 2011-09, Vol.108 (37), p.15366-15371

2011

Volltextzugriff (PDF)

Design, synthesis and SAR study of novel C2-pyrazolopyrimidine amides and amide isosteres as allosteric integrase inhibitors

Bioorganic & medicinal chemistry letters, 2020-11, Vol.30 (21), p.127516-127516, Article 127516

2020

Volltextzugriff (PDF)

Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV‑1 Integrase Inhibitors

Journal of medicinal chemistry, 2020-03, Vol.63 (5), p.2620-2637

2020

Volltextzugriff (PDF)

Influenza Nucleoprotein: Promising Target for Antiviral Chemotherapy

Antiviral Chemistry and Chemotherapy, 2013-06, Vol.23 (3), p.77-91

2013

Volltextzugriff (PDF)

Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus

Journal of Virology, 1997-05, Vol.71 (5), p.4062-4070

1997

Volltextzugriff (PDF)

pH-Dependent Changes in Photoaffinity Labeling Patterns of the H1 Influenza Virus Hemagglutinin by Using an Inhibitor of Viral Fusion

Journal of Virology, 1999-03, Vol.73 (3), p.1785-1794

1999

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(24)
Buchkapitel
(2)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Respiratory syncytial virus fusion inhibitors. Part 7: Structure–activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo

Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability

Respiratory syncytial virus fusion inhibitors. Part 5: Optimization of benzimidazole substitution patterns towards derivatives with improved activity

Respiratory syncytial virus fusion inhibitors. Part 6: An examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety

Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo

Synthesis and antiviral activity of enantiomeric forms of cyclobutyl nucleoside analogs

Respiratory syncytial virus inhibitors. Part 2: Benzimidazol-2-one derivatives

Development of a photoaffinity label for respiratory syncytial virus inhibitors

INHIBITION OF HERPES SIMPLEX VIRUS TYPE 1 DNA POLYMERASE BY THE NATURAL PRODUCT OOSPOREIN

Discovery and Development of Orally Active RSV Fusion Inhibitors

Antiviral Drug Discovery

Corrigendum to “Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability” [Bioorg. Med. Chem. Lett. 17 (2007) 895–901]

Inhibition of herpes simplex virus type 1 DNA polymerase by [1R(1 alpha,2 beta,3 alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl] guanine

Neutralization of purified herpes simplex virus DNA polymerase by two antipeptide sera

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018

Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data

5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors

Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers

Design, synthesis and SAR study of novel C2-pyrazolopyrimidine amides and amide isosteres as allosteric integrase inhibitors

Point of care testing, antibiotic prescribing and prescribing confidence for respiratory tract infections in primary care: Prospective audit in 18 European countries

Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV‑1 Integrase Inhibitors

Influenza Nucleoprotein: Promising Target for Antiviral Chemotherapy

Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus

pH-Dependent Changes in Photoaffinity Labeling Patterns of the H1 Influenza Virus Hemagglutinin by Using an Inhibitor of Viral Fusion

Suchergebnisse filtern